ChemBridge Corporation is celebrating 31 years as a global provider of enabling chemistry products and contract research services for small molecule drug discovery, chemical biology, and agrochemical discovery programs. Our extensive portfolio includes over 1.3 million diverse and target-focused small molecule screening compounds, more than 20,000 novel, synthetic macrocycles, over 14,000 chemical building blocks, our Hit2Lead.com on-line chemical store, and high-end, research-intensive custom library and synthetic/medicinal chemistry services.